Matthew DurhamOmnidynamic Marketing
Liz KaneImpactful Strategy
Matt TurnerPatient Affordability
Suma Ramadas, PhDMedical Affairs
Bud BilanichSuccess Coach
Brenda SnowAuthentic Patient Voice
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
Stacey GandlerBrand Nourishment
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Paul TheisenPatient Acquisition
MENLO PARK, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused ...
- Lefamulin met all FDA and EMA primary endpoints and was shown to be ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email